ISSN: 0272-4391
Journal Home
Journal Guideline
Drug Development Research Q2 Unclaimed
John Wiley & Sons Inc.
United States
Drug Development Research is a journal indexed in SJR in Drug Discovery with an H index of 70. It has a price of 2950 €. It has an SJR impact factor of 0,756 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,756.
Drug Development Research focuses its scope in these topics and keywords: acetaminophen, heart, dynamic, drug, dppc, diseasesynthesis, diabetic, diabetes, correlation, dysfunction, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -


Categories:
Drug Discovery (Q2)
Price
2950 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,756
SJR Impact factor70
H Index161
Total Docs (Last Year)379
Total Docs (3 years)9794
Total Refs1561
Total Cites (3 years)363
Citable Docs (3 years)4.18
Cites/Doc (2 years)60.83
Ref/DocOther journals with similar parameters
Antibodies Q2
Journal of Enzyme Inhibition and Medicinal Chemistry Q2
Current Medicinal Chemistry Q2
Biotechnology and Applied Biochemistry Q2
PPAR Research Q2
Compare this journals
Comments